x.com· @ · X·· 2026-04-22Score60
Body
#AACR26 Excited & honored to unveil initial results from the phase-2 CLOVER ☘️ trial.
CCR5-targeting
Leronlimab with
Oral chemotherapy &
VEGF-inhibitor
Enriched
Regimen
🏃♂️to our session
🔖 2-5PM
📍Section41🪧Poster14
👇🏽Promising #ctDNA💦📉
MSS #ColorectalCancer
@OncoAlert
Heat 82 · 51 likes · 7 replies · 24 reposts
Conference abstracts
1033matched by 药名 leronlimab
Leronlimab induces PD-L1 expression and is associated with long-term survival with an ICI in PD-L1 low metastatic TNBCRichard G. Pestell, Ritika Harish, Zhiping Li, Danni Li, Xuanmao Jiao, Hallgeir Rui, Massimo Cristofanilli, Daniel L. Adams, Neil E. Buss, Jonah B. Sacha, Jacob P. Lalezari
Read the abstract →6466matched by 药名 leronlimab
Preliminary results of a phase 2 study of leronlimab in combination with TAS-102 and bevacizumab in previously treated metastatic colorectal cancerPashtoon M. Kasi, Ari Baron, Arvind Chaudhry, Laura Tenner, Daniel L. Adams, Alexis B. Duffy, Hallgeir Rui, Patrick Vittner, Joseph Meidling, Jacob P. Lalezari
Read the abstract →Source: x.com · x.com